Table 1.
IFN-g, % pos | IL4, % pos | CD25, % pos | |
CD19-Fc, 1:100 | 3.0 | 2.3 | 10.3 |
ephrin-A4-Fc, 1:100 | 1.9 | 1.4 | 6.1 |
CD19-Fc, 1:10 | 10.2 | 2.6 | 19.3 |
ephrin-A4-Fc, 1:10 | 7.4 | 2.1 | 17.3 |
The reduction in T cell proliferation is not a result of a change in the Th1/Th2 ratio, but rather a general reduction in the activation status of the T cells. Resting CD4+ cells were stimulated one week with LLDC, in the presence of immobilized control protein or ligand, and re-stimulated 5 hours with TPA and ionomycin. One of three representative experiments is shown, and data represent percent of living cells staining the indicated antibody.